Category: Lung Cancer

An Update on the Burn Pits Accountability Act of 2019

an-update-on-the-burn-pits-accountability-act-of-2019

Click here to read our statement in support of the legislation. GO2 Foundation for Lung Cancer is pleased to report the recent advancement of the Burn Pits Accountability Act. We strongly support this legislation as a first step to ensure that all those affected by burn pit toxins are accounted […]

Make an Impact from Home, 7/23!

make-an-impact-from-home,-7/23!

On July 23, over 130 advocates will meet with elected officials on Capitol Hill to advocate for the lung cancer community at the GO2 Foundation National Advocacy Summit. Now you have the opportunity to strengthen the collective voice and ignite change—without leaving your home! Join us on July 23 for […]

Lung Cancer Stigma’s Harmful Consequences

lung-cancer-stigma’s-harmful-consequences

Despite increased awareness around lung cancer in recent years, the stigma associated with the disease remains an issue for the lung cancer community. Beyond the known psychosocial issues associated with this stigma, our research has revealed that both patients and oncologists feel that the stigma can actually affect the level […]

Going the Extra Mile: Jason’s Story

going-the-extra-mile:-jason’s-story

Losing a loved one to lung cancer is a pain that no one should have to experience. After Jason’s mother passed away from lung cancer in May 2018, he committed to doing something positive in her honor. On November 3, he’ll be running in the 2019 New York City Marathon as […]

Patient Needs Represented on The Hill

patient-needs-represented-on-the-hill

This week, The Hill hosted an event on Cost, Quality and Care: The Medicare Equation, where experts gathered to discuss the balancing act between Medicare affordability and quality of care. Our Co-founder, President, and CEO, Laurie Fenton Ambrose, brought the patient voice to the discussion. “Just addressing the cost of […]

New Treatment Approved for Metastatic Small Cell Lung Cancer

new-treatment-approved-for-metastatic-small-cell-lung-cancer

On June 17, 2019, the U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Though pembrolizumab is an established treatment option for […]

Early Screening Equals Early Diagnosis

early-screening-equals-early-diagnosis

GO2 Foundation for Lung Cancer’s recently published scientific paper found that lung cancer screening programs can successfully detect lung cancer early with the majority of lung cancers diagnosed at stage 1 or limited stage. Importantly, outcomes at academic and nonacademic sites were compared and the data confirmed that responsible screening […]

Lung Cancer News from the Largest Oncology Meeting

lung-cancer-news-from-the-largest-oncology-meeting

The GO2 Science and Research team just returned from the 2019 American Society of Clinical Oncology (ASCO) meeting. We connect you and your loved ones to the latest research and treatment options by keeping up with the latest advances at meetings like ASCO. While there we saw exciting presentations on […]

Latest Update to Lung-RADS (1.1) is Complete!

latest-update-to-lung-rads-(1.1)-is-complete!

Over the weekend, the long-awaited update of Lung-RADS was published with changes that aim to reduce lung cancer screening false positives by downgrading many category 3 findings to category 2. Lung-RADS (lung imaging reporting and data system) is a quality assurance tool to aid with findings in low-dose CT screenings […]

Patient Voices Were Heard: Preserving Access to Life Saving Drug Therapies!

patient-voices-were-heard:-preserving-access-to-life-saving-drug-therapies!

On May 17, 2019, The Centers for Medicare & Medicaid Services (CMS) released the final Medicare Part D Rule, where they decided to preserve the original Six Protected Classes policy. GO2 Foundation for Lung Cancer (formerly Lung Cancer Alliance and the Bonnie J. Addario Lung Cancer Foundation) advocated to stop the […]